The Danish Health Authority has confirmed that people who have received a first dose of the AstraZeneca Covid-19 vaccine will be offered a second dose from another company.
Norway's health authority has recommended AstraZeneca be withdrawn from its Covid-19 vaccination program, but the country's government has delayed a final decision until May.
Denmark’s Covid-19 vaccination programme faces significant delays following the decision by health authorities to completely withdraw the AstraZeneca vaccine from use.
The European Medicines Agency has come to the conclusion that the unusual blood clots suffered by numerous people around Europe should be considered as rare side effects of AstraZeneca's Covid-19 vaccine, but that overall the benefits of the jab outweigh the risk.
Norway on Friday extended a suspension of the use of the AstraZeneca Covid-19 vaccine until April 15th, with health officials
saying they needed more time to investigate a potential link to severe blood clotting.
Denmark on Thursday extended its suspension of the use of the AstraZeneca Covid-19 vaccine, saying it had not
ruled out a link to blood clots even though the European regulator has deemed it safe.
AstraZeneca on Wednesday denied reports it was stockpiling Covid-19 vaccines in the EU to export to Britain, after Italian inspectors found 29 million doses in a manufacturing plant near Rome.
Norway said on Thursday it would wait before resuming use of AstraZeneca's Covid-19 vaccine even though it has been declared safe by Europe's medical regulator.
The European Medicines Agency (EMA) concluded on Thursday that the AstraZeneca vaccine was a "safe and effective" tool in the battle against Covid-19 but its investigation could not rule out whether the jab had caused rare cases of blood clotting.
A group of medical experts at Oslo University Hospital said on Thursday that blood clots in three health workers who took the AstraZeneca vaccine were triggered by an immune system response.
The EU's medicines regulator said Tuesday it was "firmly convinced" the benefits of AstraZeneca's vaccine outweigh potential risks, insisting there was no evidence linking it to blood clots after several nations suspended the shot over health fears. It came as Brussels sealed a deal for 10 million more Pfizer doses.
A health worker in Norway has died of a brain haemorrhage after receiving the AstraZeneca anti-Covid vaccine, though no direct link to the jab has been established, health authorities said Monday.
Europe's medicines regulator said Thursday there appeared to be no higher risk of blood clots in those vaccinated against Covid-19, after Denmark, Norway and Iceland suspended use of the AstraZeneca jab.
Italy's medicines regulator said on Thursday it was banning a batch of the AstraZeneca/Oxford Covid vaccine as a precaution, amid fears of a link to blood clots that sparked suspensions elsewhere in Europe.
Danish health authorities said Thursday they were temporarily suspending the use of AstraZeneca's Covid-19 vaccine as
a precaution after some patients developed blood clots since receiving the jab, one of whom died.
